Serotonin is a monoamine whose role in the central nervous system encompasses a e spectrum of physiological and pathological conditions such as sleep, appetite control, aggression, anxiety, depression and schizophrenia. In addition, it participates in the modulation of vascular and endocrine functions. The serotonin transport system, localized in the plasma membrane of only a few specialized cell types, plays an important role in the control of the biological potency of this monoamine and is thus a primary target in the design and development of drugs used in the treatment of serotonin-related disorders. In addition, the serotonin transporter is at least one of the target proteins for the actions of abusable drugs such as cocaine. Despite its therapeutic and pharmacologic relevance, very little is known about the molecular characteristics and regulation of the transporter. The nucleus for the current project is the recent discovery that the human-placental syncytiotrophoblast and a cell line (JAR) of human placental origin express this transporter. The primary goal of the project is to obtain a clear understanding of the molecular and regulatory aspects of this transporter. A major part of the project will be devoted to the investigation of the transporter at the protein level. The long range goals are to understand the expression and regulation of the gene coding for the transporter and to extend these studies to the neuronal serotonin transporter. The proposed study represents a systematic approach to delineate the chemical nature of the polypeptide(s) constituting the transporter. The project is multi-faceted, aiming at purification and characterization of the transporter, functional reconstitution of the purified transporter, and hormonal regulation of the transporter function. These studies will be done using purified human placental brush border membrane vesicles as well as cultured human choriocarcinoma cells. The use of these studies in determining the operational and regulatory mechanisms of the human serotonin transporter in general is just one of the key aspects of the importance of the project. Even more significant is the potential role of serotonin in the placental function. The placenta is vital to the survival of the fetus and until now there has been no indication that serotonin has any role in the placental function. The presence of the serotonin transporter in the brush border (maternal-facing) membrane of the placenta suggests that maternally-- derived serotonin is actively transported into the syncytiotrophoblast in vivo. This opens up a new area for the potential role of serotonin in placental physiology and hence in the growth and development of the human fetus.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD027487-03
Application #
2200457
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1992-08-01
Project End
1996-06-30
Budget Start
1994-08-01
Budget End
1996-06-30
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Medical College of Georgia (MCG)
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Augusta
State
GA
Country
United States
Zip Code
30912
Prasad, P D; Hoffmans, B J; Moe, A J et al. (1996) Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta 17:201-7
Yang-Feng, T L; Ma, Y Y; Liang, R et al. (1995) Assignment of the human folate transporter gene to chromosome 21q22.3 by somatic cell hybrid analysis and in situ hybridization. Biochem Biophys Res Commun 210:874-9
Ramamoorthy, J D; Ramamoorthy, S; Mahesh, V B et al. (1995) Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells. Endocrinology 136:924-32
Ramamoorthy, S; Ramamoorthy, J D; Prasad, P D et al. (1995) Regulation of the human serotonin transporter by interleukin-1 beta. Biochem Biophys Res Commun 216:560-7
Ramamoorthy, J D; Ramamoorthy, S; Papapetropoulos, A et al. (1995) Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. J Biol Chem 270:17189-95
Ramamoorthy, J D; Ramamoorthy, S; Leibach, F H et al. (1995) Human placental monoamine transporters as targets for amphetamines. Am J Obstet Gynecol 173:1782-7
Prasad, P D; Ramamoorthy, S; Leibach, F H et al. (1995) Molecular cloning of the human placental folate transporter. Biochem Biophys Res Commun 206:681-7
Prasad, P D; Leibach, F H; Mahesh, V B et al. (1994) Human placenta as a target organ for cocaine action: interaction of cocaine with the placental serotonin transporter. Placenta 15:267-78
Jayanthi, L D; Ramamoorthy, S; Mahesh, V B et al. (1994) Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells. J Biol Chem 269:14424-9
Ganapathy, V; Leibach, F H (1994) Human placenta: a direct target for cocaine action. Placenta 15:785-95

Showing the most recent 10 out of 15 publications